Workflow
AbCellera Biologics(ABCL) - 2023 Q2 - Earnings Call Transcript

AbCellera Biologics Inc. (NASDAQ:ABCL) Q2 2023 Earnings Conference Call August 3, 2023 5:00 PM ET Company Participants Tryn Stimart - Chief Legal & Compliance Officer Carl Hansen - Chief Executive Officer & President Andrew Booth - Chief Financial Officer Conference Call Participants Andrea Tan - Goldman Sachs Antonia Borovina - Bloom Burton Steven Mah - Cowen Stephen Willey - Stifel Malcolm Hoffman - BMO Gaurav Goparaju - Berenberg Operator Good afternoon, and thank you, and welcome to AbCellera's Second Q ...